These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2557231)

  • 1. VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.
    Rouyer-Fessard C; Augeron C; Grasset E; Maoret JJ; Laboisse CL; Laburthe M
    Experientia; 1989 Dec; 45(11-12):1102-5. PubMed ID: 2557231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
    Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
    Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
    Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
    J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG; Neal DE; Simmons NL
    J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
    Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
    Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
    Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
    Griffiths NM; Rugg EL; Simmons NL
    Q J Exp Physiol; 1989 May; 74(3):339-53. PubMed ID: 2546173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
    O'Dorisio MS; Fleshman DJ; Qualman SJ; O'Dorisio TM
    Regul Pept; 1992 Feb; 37(3):213-26. PubMed ID: 1313595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells.
    Carmena MJ; Hueso C; Guijarro LG; Prieto JC
    Regul Pept; 1991 May; 33(3):287-97. PubMed ID: 1652781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
    Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line.
    Robberecht P; De Neef P; Waelbroeck M; Tastenoy M; Christophe J
    Peptides; 1989; 10(2):441-6. PubMed ID: 2474155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells.
    Crook RB; Lui GM; Alvarado JA; Fauss DJ; Polansky JR
    Curr Eye Res; 1994 Apr; 13(4):271-9. PubMed ID: 8033589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.